baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC WAR. CALL 12/24 4AB/ DE000HC3LG51 /

8/16/2024 11:41:56 AM	Chg.-	Bid1:10:44 PM	Ask8/16/2024	Underlying	Strike price	Expiration date	Option type
4.2000EUR	-	4.1100 Bid Size: 6,000	- Ask Size: 4,000	ABBVIE INC. D...	150.00 -	12/18/2024	Call

GlobeNewswire 8/29 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...

GlobeNewswire 8/28 Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference

GlobeNewswire 8/28 Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568

GlobeNewswire 8/23 NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Confere...

GlobeNewswire 8/19 TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...

GlobeNewswire 8/15 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...

GlobeNewswire 8/15 Soleno Therapeutics Announces Updates to its Board of Directors

GlobeNewswire 8/14 ArriVent BioPharma Reports Second Quarter 2024 Financial Results

GlobeNewswire 8/9 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2...

GlobeNewswire 8/8 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/8 Aligos Therapeutics Strengthens Board with Two New Independent Directors

GlobeNewswire 8/8 Genmab Announces Financial Results for the First Half of 2024

GlobeNewswire 8/8 Genmab Updates 2024 Financial Guidance

GlobeNewswire 8/8 Royalty Pharma Reports Second Quarter 2024 Results

GlobeNewswire 8/7 Alector Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/6 Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/1 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...

GlobeNewswire 8/1 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 8/1 NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer

GlobeNewswire 8/1 Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc.

GlobeNewswire 7/31 Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors

GlobeNewswire 7/31 Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV111, a CD19 Directed in situ CAR...

GlobeNewswire 7/30 Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...

GlobeNewswire 7/28 Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzhei...

GlobeNewswire 7/25 Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Tre...

UC WAR. CALL 12/24 4AB/ DE000HC3LG51 /

If you wish to receive reply to your feedback, please provide your email address.